title: Paraneoplastic pemphigus in association with B-cell lymphocytic leukemia and hepatitis C: favorable response to intravenous immunoglobulins and prednisolone.
authors.forename: Mousumee
authors.initials: M
authors.lastname: Nanda
authors.forename: Arti
authors.initials: A
authors.lastname: Nanda
authors.forename: Humoud
authors.initials: H
authors.lastname: Al-Sabah
authors.forename: Richard
authors.initials: R
authors.lastname: Dvorak
authors.forename: Qasem A
authors.initials: QA
authors.lastname: Alsaleh
mesh_terms: D051184:Desmoglein 3 / Q000276:immunology; D005455:Fluorescent Antibody Technique; D005938:Glucocorticoids / Q000627:therapeutic use; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D010392:Pemphigus / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D011239:Prednisolone / Q000627:therapeutic use; D012867:Skin / Q000473:pathology*
chemical_list: C071894:DSG3 protein, human; D051184:Desmoglein 3; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D011239:Prednisolone